Replimune REPL
NASDAQ REPL
$23.28 +1.02 (+4.58%)
At close: Nov 10, 2026 · 4:00 PM EST

Replimune (REPL) Liabilities and Shareholders Equity (2018 - 2026)

Updated

Analysis

Replimune (REPL) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 197.43 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 147.68 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 115.83 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 51.41 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 205.00 Bn
10 Replimune 2.40 Bn 1.35 Bn - 373.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 373.94 Mn
Jun 30, 2026 252.45 Mn
Mar 31, 2026 332.39 Mn
Dec 31, 2025 333.59 Mn
Sep 30, 2025 389.45 Mn
Jun 30, 2025 469.51 Mn
Mar 31, 2025 551.33 Mn
Dec 31, 2024 603.63 Mn
Sep 30, 2024 498.20 Mn
Jun 30, 2024 534.97 Mn
Mar 31, 2024 487.72 Mn
Dec 31, 2023 532.93 Mn
Sep 30, 2023 562.40 Mn
Jun 30, 2023 603.89 Mn
Mar 31, 2023 646.59 Mn
Dec 31, 2022 678.55 Mn
Sep 30, 2022 436.10 Mn
Jun 30, 2022 459.43 Mn
Mar 31, 2022 461.19 Mn
Dec 31, 2021 485.28 Mn
API Access

Replimune Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=REPL&period=max&api_key=YOUR_API_KEY